Chemed Corp. buy Royal Bank of Canada
Start price
30.10.23
/
50%
€530.00
Target price
30.10.24
€568.73
Performance (%)
-7.27%
Price
22.07.24
€492.00
Summary
This prediction is currently active. With a performance of -7.27%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. Dividends of €1.49 are taken into consideration when calculating the performance. This prediction currently runs until 30.10.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Chemed Corp. | 5.102% | 5.102% |
iShares Core DAX® | -0.543% | 1.491% |
iShares Nasdaq 100 | -2.696% | -1.235% |
iShares Nikkei 225® | -2.863% | 2.491% |
iShares S&P 500 | -1.105% | 0.013% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Chemed Corp. diskutieren
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $576.00 to $604.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat